Abstract
Nanotheranostics is a novel and unique nanomedicine approaches for highly developed theranostics. The functional nanoprobes that can perform additional therapeutic modalities in cancer disease control have emerged over the past three decades. In this chapter, we summarize the several nanocarriers developed in the previous literature for nanotheranostics, such as carbon nanotubes, liposomes, dendrimers, inorganic and metal nanoparticles, and polymer conjugates for controlled sustained, and target-specific codelivery of therapeutic and diagnostic agents to improving the theranostic effects. Theranostic nanomedicine may acquire systemic circulation and escape host defenses as well as deliver the therapeutic agents to treat the illness at the molecular and cellular level. In nanomedicine, the diagnostic and therapeutic agents are designed as a single theranostic network that may be ligated to the biological moiety for targeting. Besides, theranostics nanomedicine may stimulate synergetic and combinatory therapy, oral delivery, stimuli-responsive release, multimodality therapies, and escape from intracellular autophagy. This approach will provide a strong prognosis for personalized therapy that renders the serious diseases treatable or diagnosed the illness at its earlier stage.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
